We specialize in providing comprehensive advisory services for private and public companies and for owners in all types of capital transactions, including capital raising through private and public (preIPO, IPO and SPO, Private PLacement) share issues, introduction to listing on Warsaw Stock Exchange main market and NewConnect alternative market, as well as mergers and acquisitions advisory. We are WSE’s Partner Company for SMEs, we fulfill the role of Authorized Advisor for NewConnect.



Master Pharm Group: PLN 15 million revenue and PLN 1.1 million net profit in Q1

The Group's revenues in the first quarter of this year, amounting to nearly PLN 15 million, were at a level lower by 16% yoy. They translated into net profit of PLN 1.1 million, which means a decrease by 63%, mainly related to the impact of fixed costs, with a lower level of revenues in the companies Master Pharm and Avet Pharma.


The Lubawa Group increased sales and results

In 2018, the Group recorded PLN 239.6 million revenue (+ 4% yoy) and PLN 6.6 million net profit (+ 183% yoy).